ArticleEuropean heart journal open2026

Glucagon-like peptide-1 receptor agonists are associated with cardiac, cancer- and mortality-related benefits in diabetic patients treated with anthracyclines.

Sunnia T Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.